antispameurope closes additional funding round

July 7, 2009

Neuhaus Partners and High-Tech Gründerfonds have increased their shares in antispameurope. The inflow of additional capital is expected to further strengthen international growth of the Hannover based provider of managed e-mail security services.

Both companies are investors into antispameurope since its first financing round in the fall of 2007. A second financing round was conducted in April of 2008. Dr. Gottfried Neuhaus, Managing Partner of Neuhaus Partners, appears pleased with the development of his investment: “antispameurope is being outstandingly well-positioned in the market. This is confirmed not only by the increasing number of customers, but also by the apparent interest in the company antispameurope.”

Holger Heinen, Senior Investment Manager at High-Tech Gründerfonds, gives his reasons for the continued involvement: “We have high expectations for the continued development of antispameurope. The current financing round not only strengthens our position, but also promotes the company’s continued growth.”

antispameurope will use the additional funds mainly to push for additional expansion of their international activities. As managing director of antispameurope, Oliver Dehning is responsible for international development: “We have already achieved some first successes in Italy and Spain. We intend to convert the initial achievements into positive growth, similar to what we’ve done in Germany and at the same time use our experiences from Spain and Italy to expand our business into other countries and continue our growth path”.

About antispameurope:
antispameurope is leading provider of managed e-mail security services. Their premium services are compatible with all current e-mail systems without additional software, hardware or maintenance requirements – even for mobile phone users. The services offered include spam and virus filters, automatic e-mail signature and archiving solutions. All services are provided via several secure data centers and are accessible around the clock, every day of the year. Apart from corporate clients, the security specialist also offers its services to internet service and hosting providers as well as other sales partners for their clients.

For more details about antispameurope please visit

About Neuhaus Partners:
Neuhaus Partners GmbH is based in Hamburg and is one of the leading venture capital companies in Europe, investing primarily in information technology companies. Since its founding in 1998, the company has completed 48 investments and in 44 of those Neuhaus Partners participated as lead investor. Track Record: Two IPO’s, sixteen trade sales, three buy backs and ten insolvencies. Neuhaus Partners is currently investing in its third fund generation.

For more information about Neuhaus Partners please visit

About High-Tech Gründerfonds:
High-Tech Gründerfonds invests in new, up-and-coming technology companies who are converting promising research results into entrepreneurial success. Using seed financing of up to 500,000 euros, the start-ups are set to implement R & D plans that will culminate in the final assembly of a prototype or a proof of concept or introduction onto the market. High-Tech Gründerfonds manages funds worth approximately 272 million euros. Investors of the public-private partnership include the Federal Ministry of Economics and Technology, the KfW banking group, the six industrial concerns of BASF, Deutsche Telekom, Siemens, Robert Bosch, Daimler and Carl Zeiss.

For more details about High-Tech Gründerfonds please visit

For further information regarding this press release please contact:

antispameurope GmbH
Oliver Dehning
Tel.: +49 (511) 260 905-0
Fax: +49 (511) 260 905-99

Neuhaus Partners GmbH
Thomas Golinski
Tel.: +49 (40) 355 282-0
Fax: +49 (40) 355 282-39

High-Tech Gründerfonds Management GmbH
Holger Heinen
Ludwig-Erhard-Allee 2
53175 Bonn
Tel.: +49 (228) 965 685-00
Fax: +49 (228) 965 685-50

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

10. July 2024

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX Dr. Linda Greenbaum joins HepaRegeniX as CMO Tuebingen (Germany), July 10, 2024 – HepaRegeniX GmbH, a clinical stage company developing novel regenerative therapies for the treatment of acute and chronic liver diseases, today announced the closing of a Series C rou
9. July 2024

SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases.

The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy. Munich, Germany, July 9, 2024 – SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic iRhom2 antibodies, announced today the closing of a EUR 63 million (USD 70 million) Series A financing round. The round was co-led by Andera Pa